4-amino-1-((2R,3S,5S)-2-(hydroxymethyl)-3-oxido-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one

Catalog No. :
ACOCLJ071
CAS No. :
160552-55-6
Molecular Formula :
C8H11N3O4S
Molecular Weight :
245.26

IUPAC Name:4-amino-1-((2R,3S,5S)-2-(hydroxymethyl)-3-oxido-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one

4-amino-1-((2R,3S,5S)-2-(hydroxymethyl)-3-oxido-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-amino-1-((2R,3S,5S)-2-(hydroxymethyl)-3-oxido-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one
IUPAC Name4-amino-1-((2R,3S,5S)-2-(hydroxymethyl)-3-oxido-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one
Molecular FormulaC8H11N3O4S
Molecular Weight245.26
SMILESNC1=NC(=O)N([C@@H]2C[S@](=O)[C@H](CO)O2)C=C1
InChI KeyLJMQAXFNQNADRZ-RAPPMSLKSA-N
Synonym4-amino-1-((2R,3S,5S)-2-(hydroxymethyl)-3-oxido-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one;Lamivudine EP Impurity H;lamivudine sulfoxide;Lamivudine Impurity 7(Lamivudine EP Impurity G);Lamivudine Impurit Ⅳ:4-amino-1-((2R,3S,5S)-2-(hydroxymethyl)-3-oxido-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one;Lamivudine EP IMP G;2(1H)-Pyrimidinone, 4-amino-1-[(2R,3S,5S)-2-(hydroxymethyl)-3-oxido-1,3-oxathiolan-5-yl]- (9CI);Lamivudine (S)-Sulfoxide
CAS No.160552-55-6

Synthetic Route by SureRoute

1. ACOCLJ071 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOCLJ071 route product structure diagram
    ACOCLJ071160552-55-6
Inquiry

2. ACOCLJ071 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOCLJ071 route product structure diagram
    ACOCLJ071160552-55-6
Inquiry

Comments (0)